|
 
Health Effects Assessment Summary (HEAST) for
Heptachlor Epoxide
CAS: 001024-57-3
Summary of HEAST Information on-Line
|
|
Subchronic and Chronic Toxicity |
|
Carcinogenicity |
|
|
|
|
|
Subchronic and Chronic Toxicity
(Other than Carcinogenicity) |
|
Subchronic [RfD]: (see comment) |
1.3E-5 mg/kg/day |
|
Uncertainty Factor: |
1000 |
|
Route: |
Oral: diet |
|
Target Organ / Critical Effect: |
Liver / Increased relative weight |
|
Species |
Effect Level |
Dose |
Experiment Length |
Dog |
LOAEL |
0.0125 mg/kg/day |
60 weeks |
|
References |
1958 | Dow Chemical Co. 1958. MRID No. 00061912. Available from EPA. Write to FOI, EPA, Washington, DC 20460. |
1986 | U.S. EPA. 1986. RfD/RfC Work Group. |
|
Subchronic [RfD] Comments: |
The chronic oral RfD was adopted as the subchronic oral [RfD]. |
|
|
|
|
Carcinogenicity |
|
Inhalation [Slope Factor]: (see comment) | 9.1E+0 (mg/kg/day)-1 |
|
|
Route: |
Oral: diet |
|
Target Organ / Cancer: |
Liver / Carcinoma |
|
Species |
Experiment Length |
EPA Group |
Mouse |
18-24 months |
IRIS |
|
References |
1965 | Davis K.J. 1965. Pathology report on mice fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehman. July 19. |
1973 | Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, DC 20460. |
1987 | U.S. EPA. 1987. Carcinogen Risk Assessment Verification Endeavor (CRAVE) Work Group. |
|
Inhalation Slope Comment: |
Based on route to route extrapolation. See Appendix A-II, Dose Conversions on HEAST. |
|
[ Risk Assessment Home ]
[ EPA Home |
OSWER Home | Superfund Home ]
[ Search EPA
| Search Superfund
| Whats New |
Contact Us ]
URL: http://risk.lsd.ornl.gov/epa/heast/heast_select.htm
This page was last updated on: March 1, 2000
Site maintained by: Office of Emergency and Remedial Response
Hofmann.Lee@epamail.epa.gov
|